Barrett Thornhill is named as a lobbyist on federal disclosure filings for 33 clients through Forbes-tate. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Medicare/Medicaid, Budget/Appropriations and Trade (domestic/foreign).
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| ULTRAGENYX PHARMACEUTICAL | FORBES-TATE | Q3 2026 | Health Issues |
| INVIVYD | FORBES-TATE | Q3 2026 | Health Issues |
| CAI INVESTMENTS | FORBES-TATE | Q3 2026 | Trade (domestic/foreign), Medical/Disease Research/Clinical Labs, Budget/Appropriations |
| YTY | FORBES-TATE | Q3 2026 | Manufacturing |
| VIR BIOTECHNOLOGY, INC. | FORBES-TATE | Q3 2026 | Health Issues |
| THE CURE COALITION | FORBES-TATE | Q3 2026 | Health Issues, Budget/Appropriations |
| TENNESSEE RURAL HEALTH IMPROVEMENT ASSOCIATION | FORBES-TATE | Q3 2026 | Health Issues |
| TARSUS PHARMACEUTICALS | FORBES-TATE | Q3 2026 | Health Issues |
| SYDNEXIS | FORBES-TATE | Q3 2026 | Health Issues |
| PHRMA | FORBES-TATE | Q3 2026 | Trade (domestic/foreign), Medicare/Medicaid, Health Issues |
| NOVARTIS, INC. | FORBES-TATE | Q3 2026 | Trade (domestic/foreign), Budget/Appropriations, Taxation/Internal Revenue Code |
| GENENTECH | FORBES-TATE | Q3 2026 | Budget/Appropriations, Taxation/Internal Revenue Code, Medicare/Medicaid |
| ASSOCIATION OF AMERICAN MEDICAL COLLEGES | FORBES-TATE | Q3 2026 | Education, Health Issues, Medicare/Medicaid |
| AMGEN USA, INC. | FORBES-TATE | Q3 2026 | Taxation/Internal Revenue Code, Medicare/Medicaid, Medical/Disease Research/Clinical Labs |
| MERCK KGAA DARMSTADT GERMANY | FORBES-TATE | Q3 2026 | Trade (domestic/foreign), Chemicals/Chemical Industry, Manufacturing |
| IONIS PHARMACEUTICAL, INC. | FORBES-TATE | Q3 2026 | Medicare/Medicaid, Health Issues |
| HALOZYME THERAPEUTICS, INC. | FORBES-TATE | Q3 2026 | Medicare/Medicaid, Health Issues |
| GLOBAL MEDICAL RESPONSE | FORBES-TATE | Q3 2026 | Medicare/Medicaid, Health Issues, Veterans |
| GILEAD SCIENCES, INC. | FORBES-TATE | Q3 2026 | Health Issues |
| BIO-RAD LABORATORIES | FORBES-TATE | Q3 2026 | Defense, Medicare/Medicaid, Health Issues |
| CLARITEV (FKA MULTIPLAN CORPORATION) | FORBES-TATE | Q2 2026 | Labor Issues/Antitrust/Workplace, Medicare/Medicaid, Health Issues |
| ANAVEX LIFE SCIENCES | FORBES-TATE | Q1 2026 | Health Issues |
| VIZGEN INC. | FORBES-TATE | Q4 2025 | Health Issues |
| ANTIMICROBIAL INNOVATION ALLIANCE | FORBES-TATE | Q4 2025 | Health Issues |
| REVANGENIX | FORBES-TATE | Q4 2025 | Health Issues |
| DENTSPLY SIRONA | FORBES-TATE | Q4 2025 | Trade (domestic/foreign), Medicare/Medicaid, Health Issues |
| HOPEWELL FUND | FORBES-TATE | Q3 2025 | Health Issues |
| CSL BEHRING | FORBES-TATE | Q3 2025 | Medicare/Medicaid, Medical/Disease Research/Clinical Labs |
| HEALTHY.IO (US), INC. | FORBES-TATE | Q2 2025 | Medicare/Medicaid, Health Issues |
| LYKOS THERAPEUTICS | FORBES-TATE | Q2 2025 | Veterans, Health Issues |
| CYTOVALE, INC. | FORBES-TATE | Q1 2025 | Medicare/Medicaid, Health Issues |
| SAFE AND ETHICAL PPE ACCESS ALLIANCE | FORBES-TATE | Q1 2025 | Manufacturing |
| SIGNIFIER MEDICAL TECHNOLOGIES LIMITED | FORBES-TATE | Q1 2025 | Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 22 | 1 |
| 2025 | 30 | 1 |
| Year | Items | Total |
|---|---|---|
| 2026 | 1 | $2K |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Barrett Thornhill. See the Capitol Clarity rankings and method.